Risk Intelligence
El Niño impact on monsoons
View Risks →Godrej Agrovet delivered a strong Q4 FY26 with consolidated revenue of ₹2,333 crore (+9% YoY) and PBT growth of 16.8% to ₹87 crore.
✓ Verified against BSE filing
Godrej Agrovet delivered a strong Q4 FY26 with consolidated revenue of ₹2,333 crore (+9% YoY) and PBT growth of 16.8% to ₹87 crore. Full-year revenue crossed ₹10,000 crore milestone at ₹10,233 crore (+9% YoY), with PBT up 17.2% to ₹569 crore. Performance was driven by volume-led growth in animal nutrition (cattle feed volumes +24%), record oil palm area expansion and extraction ratio improvement, and Aztec Life Sciences turning EBITDA positive. Management guided for early double-digit revenue growth and mid-teens PBT growth in FY27, with capex of ~₹350-400 crore and free cash flow of ₹100-125 crore. Key risks include potential El Niño impact on monsoons and Iran war uncertainty affecting palm oil prices and crop protection demand.
El Niño impact on monsoons
View Risks →Full transcript text is available on this route.
Read Transcript →Cattle feed volumes increased sharply by 24% in Q4, significantly ahead of industry growth.
Oil extraction ratio improved to 20.77% in Q4 from 19.76% last year, indicating better productivity.
CDMO contributed 52% of Aztec revenue in FY26; enterprise 48%. Mix expected similar for next two years.
Branded revenue salience remained above 80% in FY26, up from 78% last year, driven by strategic shift.
Management targets early double-digit consolidated revenue growth for FY27, driven by volume growth across segments.
Below-normal monsoon predictions could affect crop protection and animal feed demand, though management believes impact may be mitigated by geograp...
View Risks →